• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » Everlywell, Nurx to offer at-home COVID-19 tests

Everlywell, Nurx to offer at-home COVID-19 tests

March 19, 2020 By Nancy Crotti

(Image from Unsplash)

Home testing company Everlywell said today that it will launch a home test kit with telehealth diagnosis for COVID-19 on Monday.

The Austin, Texas-based company said it will release 30,000 tests immediately and is working with multiple labs to have testing and diagnosis capacity for a quarter of a million people weekly.

Consumers who have COVID-19 symptoms can order the test online and send completed test kits overnight to a CLIA-certified laboratory. Secure digital results will be available online within 48 hours of the lab receiving the sample, and free telehealth consultations with an independent, board-certified physician will be available for those with positive results, according to Everlywell. Cooperating labs are complying with the FDA’s Emergency Use Authorization for COVID-19 testing, the company added.

The test will be available from the company for $135 at no profit to Everlywell, and will be covered by participating HSA and FSA providers. Everlywell said it has asked government officials and public health departments if the test can be made available for free.

Also offering an at-home test kit are testing provider Nurx and its lab partner, Molecular Testing Labs (Vancouver, Wash.), who said they will launch home testing for the virus and telehealth consultations within the week for people who have been exposed to the coronavirus or who are exhibiting symptoms. Nurx healthcare practitioners will screen patients for testing and have the lab ship tests overnight to those who need them. If the test comes back positive, the Nurx provider will advise on next steps, according to the San Francisco-based company.

“For those who we believe are at high-risk, we will be recommending in-person care. Our ability to provide testing will be responsive and dynamic to leading clinical public health guidelines,” Nurx said on its website.

Other companies announced they intend to boost to the supply of in-person COVID-19 tests in the U.S. China-based precision medicine company 3DMed is seeking FDA approval of tests for COVID-19 and COVID-19/influenza A and B, and a countertop PCR machine, which have all received the CE Mark.

3DMed has signed an agreement for Rehovot, Israel-based Todos Medical to distribute the tests in the U.S. and Israel, with U.S. testing to take place in Provista Diagnostics’ lab in Alpharetta, Ga., according to Todos. 3D BioMed has shipped materials to the Provista lab to support the validation being conducted over the coming weeks, the Israeli company added.

“The main differentiation in the 3DMed offering versus other nucleic acid PCR-based testing is the influenza A and B tests combined with coronavirus testing,” said Todos chief medical advisor Jorge Leon in a news release. “This is a clinically meaningful combination because of the extended flu season in the United States that will create additional doubt among healthcare providers regarding the cause of symptoms for patients. The fact that this will be available in one testing paradigm seems to be novel in the United States.”

3DMed learned a great deal during the coronavirus outbreak in Wuhan, China, and wants to share its experiences with the rest of the world, according to company president & CEO Simon Shung.

“Fully automated viral RNA extraction systems and precise nucleic acid detection kits played critical roles in rapidly diagnosing coronavirus disease (in) 2019 with a large scale in Wuhan, China,” Shung said. “Meanwhile, to distinguish between early symptoms of the flu and coronavirus would become very important since people may feel similar to those suffering from their symptoms. We hope to help the U.S. and other countries stop the coronavirus spreading through the collaboration with Todos by doing more precise nucleic acid tests with our products, which were validated by tons of cases in the past few months.”

Separately, CPT Medical, a surgical pack and kit manufacturing firm based in Greenville, S.C., announced it has 54,000 COVID-19 test kits in production for shipment to hospitals, nursing homes, and physician’s offices by the end of next week. The company said it is scheduled to release 95,000 test kits for patient testing in approximately 3 weeks.

CPT said it is also developing an at-home test for physicians to order for their patients to keep virus transmission rates down.

Also, molecular diagnostic company Mesa Biotech said it has won a $561,000 contract from the U.S. Department of Health and Human Services (HHS) to develop a point-of-care COVID-19 test that can provide results in 30 minutes. The Accula SARS-CoV-2 test will be developed on the company’s commercially available platform for Accula Flu A/Flu B and RSV Test, which are both 510(k)-cleared and CLIA-waived.

“As the coronavirus situation escalates and the demand for testing far exceeds capacity, we are encouraged by the support of HHS in the development of our Accula SARS-CoV-2 Test,” said Mesa Biotech CEO Hong Cai. “Our test, which was developed to enable rapid responses to global pandemics, will significantly compress the sample-to-result timeframe with a laboratory-quality test at the point-of-care. This accelerated response will enable health care providers to rapidly screen, isolate, treat or dismiss potential carriers of the virus.”

Filed Under: Blog Tagged With: 3DMed, coronavirus, CPT Medical, Everlywell, Mesa Biotech, Nurx, Provista Diagnostics, Todos Medical, U.S. Department of Health and Human Services

In case you missed it

  • DTW Podcast: Herrera on how military lessons led to Medtech career; Ulmer ready to redo landmark FDA survey
  • EMA begins investigation of J&J COVID-19 vaccine’s blood clotting potential
  • Johnson & Johnson COVID-19 vaccine shipments plunge
  • Medtronic stent graft recall is serious
  • Olympus opens new U.S. medical business HQ in Massachusetts
  • Crown Aesthetics wins FDA clearance for wrinkle treatment device
  • FDA clears Activ Surgical hardware for enhanced surgical visualization
  • FDA tells hospitals: Stop reusing disposable masks
  • Outset Medical to raise nearly $366M from primary, upsized offerings
  • Are Black patients not getting LVADs as quickly as white patients?
  • St. Jude Medical founder and his Medical 21 raise $3M
  • Google, Varian partner on AI to boost cancer radiation therapy
  • How can medtech companies use more patient input to improve clinical trials?
  • FDA advisory committee positive about TransMedics’ OCS Heart system
  • Hologic to acquire Mobigiag in $795M deal
  • Dräger acquires majority share of Stimit and its tech to help people breathe
  • Sandia Labs seeks partners to make reusable masks

RSS From Medical Design & Outsourcing

  • Resonetics to expand manufacturing in Costa Rica
    Resonetics announced today it has leased new manufacturing space in Costa Rica to more than double its production there. The space, in a building near its current site in the Coyol Free Zone business park in Alajuela, will be expanded and reconfigured to create a 45,000 ft² production site. The move comes after the company… […]
  • Are Black patients not getting LVADs as quickly as white patients?
    Researchers from the University of Missouri conducted a study that found disparities in treating Black and white patients with advanced heart failure. According to a news release, the study found that Black patients with advanced heart failure were more likely to receive a left ventricular assist device (LVAD) — a pump implanted into the chest… […]
  • Viant expands factory in Costa Rica
    Viant announced today that it has completed a major expansion of its medical device manufacturing facility in Heredia, Costa Rica. The company said it invested in the additional capacity to meet market demand for minimally invasive surgical devices, including energy-based devices. Begun in fall 2020, the expansion adds 14,000 ft² of ISO Class 8 cleanroom… […]
  • St. Jude Medical founder and his Medical 21 raise $3M
    Raising money for a startup company during a pandemic is no cakewalk, according to Manny Villafaña. But he did it. Medical 21, the latest venture for the founder of St. Jude Medical, has raised another $3 million in an equity offering, according to an SEC filing. The most recent round brings the Minneapolis-based startup’s total funding… […]
  • How can patient input improve clinical trials?
    The Medical Device Innovation Consortium (MDIC) has laid out some recommendations for improving medical device clinical trials with increased patient input. Having observed that clinical trial sponsors seldom refer to patient input — something the FDA issued guidance for in September 2019 — MDIC offered its view on increasing and using patient input to improve… […]
  • Orchid names new CFO
    Orchid Orthopedic Solutions (Holt, Mich.) announced this week that Matt Tharp has joined the company as chief financial officer. Tharp comes to Orchid from Ammega, where he held the role of CFO – Americas. He has more than 20 years of experience in supply chain, operations and finance and has held leadership roles at Midwest… […]
  • ICS establishes dedicated medical device practice
    Integrated Computer Solutions (ICS) is establishing a dedicated medical device practice amid increased demand for complex medtech. ICS said its work in the medical and life sciences markets has nearly doubled year-over-year as connected technologies drive innovation and transform healthcare. “There has been extraordinary innovation and growth in the medtech sector in recent years which… […]
  • SMC is expanding its Costa Rica facility
    SMC (Somerset, Wis.) recently announced that it will double the size of its Alajuela, Costa Rica facility to 120,000 ft2 this year. The additional space will enable SMC Costa Rica to provide increased contract manufacturing solutions, including assembly, injection molding and secondary operations. SMC plans to double the number of workers it has in the Central… […]
  • Sandia Labs seeks partners to make reusable masks
    Sandia National Laboratories has come up with its own version of a reusable respirator for frontline workers. Sandia has filed for patent protection, is testing prototypes, and seeking NIOSH approval and potential manufacturing partners for its elastomeric half-mask N95 respirator. It’s the latest entry to a small but growing category of reusable masks designed to… […]
  • Evco Plastics adds Ga. plant for medtech production
    Evco Plastics (DeForest, Wis.) announced today that it recently purchased a new facility for white room and liquid silicone rubber molding near Calhoun, Ga. The CAL 2 facility has room for 20 injection molding machines of up to 500 tons, and there will be a separate room for new LSR machines. Other features of CAL… […]
  • ABC debuts drama about evil medtech company
    ABC-TV will this week begin airing “Rebel,” an Erin Brockovich-inspired drama in which the main character investigates a fictional medtech company. Stonemore Medical manufactures heart valves that cause autoimmune problems in 3,000 patients, according to ABC. Rebel stars Katey Sagal as Annie “Rebel” Bello, Tamala Jones as Rebel’s ex-sister-in-law Lana, John Corbett as Grady Bello… […]

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS